(GTLB) Gitlab - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US37637K1088
Stock: DevSecOps Platform, Cloud, Training, Consulting
Total Rating 19
Risk 51
Buy Signal -1.77
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 56.6% |
| Relative Tail Risk | -8.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.00 |
| Alpha | -72.02 |
| Character TTM | |
|---|---|
| Beta | 1.443 |
| Beta Downside | 1.774 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.42% |
| CAGR/Max DD | -0.22 |
Description: GTLB Gitlab January 06, 2026
GitLab Inc. (NASDAQ:GTLB) delivers an integrated DevSecOps platform that spans the entire software development lifecycle-from project planning and source-code management to security testing, CI/CD, artifact packaging, deployment, and production monitoring-enabling enterprises to manage and secure applications across multi-cloud environments through a single interface.
Founded in 2011 and headquartered in San Francisco, the company went public in 2021 and reported FY2023 revenue of approximately $532 million, representing a 30% year-over-year increase, with annual recurring revenue (ARR) surpassing $1.2 billion and gross margins hovering around 80%.
The DevSecOps market is expanding at roughly 15% CAGR, driven by accelerated cloud adoption, heightened cybersecurity mandates, and the need for faster software delivery cycles; GitLab competes with players such as Atlassian, Microsoft (Azure DevOps), and GitHub, but differentiates itself through its single-application approach and strong community-driven ecosystem.
For a deeper dive into GitLab’s valuation metrics, you might find ValueRay’s analyst notes useful.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: -47.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 23.83 > 1.0 |
| NWC/Revenue: 103.8% < 20% (prev 102.3%; Δ 1.59% < -1%) |
| CFO/TA 0.16 > 3% & CFO 250.3m > Net Income -47.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (166.0m) vs 12m ago 1.04% < -2% |
| Gross Margin: 88.01% > 18% (prev 0.89%; Δ 8712 % > 0.5%) |
| Asset Turnover: 64.19% > 50% (prev 56.81%; Δ 7.39% > 0%) |
| Interest Coverage Ratio: -2.74 > 6 (EBITDA TTM -73.7m / Interest Expense TTM -30.9m) |
Altman Z'' -1.13
| A: 0.60 (Total Current Assets 1.51b - Total Current Liabilities 565.8m) / Total Assets 1.57b |
| B: -0.78 (Retained Earnings -1.22b / Total Assets 1.57b) |
| C: -0.06 (EBIT TTM -84.7m / Avg Total Assets 1.41b) |
| D: -2.02 (Book Value of Equity -1.22b / Total Liabilities 602.8m) |
| Altman-Z'' Score: -1.13 = CCC |
Beneish M -3.26
| DSRI: 0.88 (Receivables 221.1m/197.6m, Revenue 906.3m/711.6m) |
| GMI: 1.01 (GM 88.01% / 89.00%) |
| AQI: 0.76 (AQ_t 0.03 / AQ_t-1 0.05) |
| SGI: 1.27 (Revenue 906.3m / 711.6m) |
| TATA: -0.19 (NI -47.6m - CFO 250.3m) / TA 1.57b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of GTLB shares?
As of February 02, 2026, the stock is trading at USD 34.98 with a total of 3,565,432 shares traded.
Over the past week, the price has changed by -8.36%, over one month by -3.32%, over three months by -31.47% and over the past year by -50.54%.
Over the past week, the price has changed by -8.36%, over one month by -3.32%, over three months by -31.47% and over the past year by -50.54%.
Is GTLB a buy, sell or hold?
Gitlab has received a consensus analysts rating of 4.54.
Therefore, it is recommended to buy GTLB.
- StrongBuy: 18
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GTLB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 51 | 45.7% |
| Analysts Target Price | 51 | 45.7% |
| ValueRay Target Price | 31.9 | -8.9% |
GTLB Fundamental Data Overview February 02, 2026
P/E Forward = 31.9489
P/S = 6.5
P/B = 6.4789
Revenue TTM = 906.3m USD
EBIT TTM = -84.7m USD
EBITDA TTM = -73.7m USD
Long Term Debt = 392.0k USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 275.0k USD (from shortTermDebt, last fiscal year)
Debt = 392.0k USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -224.2m USD (from netDebt column, last quarter)
Enterprise Value = 4.69b USD (5.89b + Debt 392.0k - CCE 1.20b)
Interest Coverage Ratio = -2.74 (Ebit TTM -84.7m / Interest Expense TTM -30.9m)
EV/FCF = 19.34x (Enterprise Value 4.69b / FCF TTM 242.3m)
FCF Yield = 5.17% (FCF TTM 242.3m / Enterprise Value 4.69b)
FCF Margin = 26.74% (FCF TTM 242.3m / Revenue TTM 906.3m)
Net Margin = -5.25% (Net Income TTM -47.6m / Revenue TTM 906.3m)
Gross Margin = 88.01% ((Revenue TTM 906.3m - Cost of Revenue TTM 108.6m) / Revenue TTM)
Gross Margin QoQ = 86.81% (prev 87.92%)
Tobins Q-Ratio = 2.98 (Enterprise Value 4.69b / Total Assets 1.57b)
Interest Expense / Debt = 1849 % (Interest Expense 7.25m / Debt 392.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = -66.9m (EBIT -84.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.66 (Total Current Assets 1.51b / Total Current Liabilities 565.8m)
Debt / Equity = 0.00 (Debt 392.0k / totalStockholderEquity, last quarter 922.7m)
Debt / EBITDA = 3.04 (negative EBITDA) (Net Debt -224.2m / EBITDA -73.7m)
Debt / FCF = -0.93 (Net Debt -224.2m / FCF TTM 242.3m)
Total Stockholder Equity = 843.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.37% (Net Income -47.6m / Total Assets 1.57b)
RoE = -5.64% (Net Income TTM -47.6m / Total Stockholder Equity 843.4m)
RoCE = -10.03% (EBIT -84.7m / Capital Employed (Equity 843.4m + L.T.Debt 392.0k))
RoIC = -7.93% (negative operating profit) (NOPAT -66.9m / Invested Capital 843.4m)
WACC = 11.23% (E(5.89b)/V(5.89b) * Re(11.23%) + (debt cost/tax rate unavailable))
Discount Rate = 11.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.44%
[DCF Debug] Terminal Value 57.23% ; FCFF base≈242.3m ; Y1≈159.1m ; Y5≈72.6m
Fair Price DCF = 7.64 (EV 920.2m - Net Debt -224.2m = Equity 1.14b / Shares 149.8m; r=11.23% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 65.56 | EPS CAGR: 107.3% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.62 | Revenue CAGR: 35.69% | SUE: 1.98 | # QB: 2
EPS next Quarter (2026-04-30): EPS=0.20 | Chg30d=-0.002 | Revisions Net=-3 | Analysts=23
EPS next Year (2027-01-31): EPS=1.03 | Chg30d=-0.007 | Revisions Net=-1 | Growth EPS=+14.7% | Growth Revenue=+19.1%
P/S = 6.5
P/B = 6.4789
Revenue TTM = 906.3m USD
EBIT TTM = -84.7m USD
EBITDA TTM = -73.7m USD
Long Term Debt = 392.0k USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 275.0k USD (from shortTermDebt, last fiscal year)
Debt = 392.0k USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -224.2m USD (from netDebt column, last quarter)
Enterprise Value = 4.69b USD (5.89b + Debt 392.0k - CCE 1.20b)
Interest Coverage Ratio = -2.74 (Ebit TTM -84.7m / Interest Expense TTM -30.9m)
EV/FCF = 19.34x (Enterprise Value 4.69b / FCF TTM 242.3m)
FCF Yield = 5.17% (FCF TTM 242.3m / Enterprise Value 4.69b)
FCF Margin = 26.74% (FCF TTM 242.3m / Revenue TTM 906.3m)
Net Margin = -5.25% (Net Income TTM -47.6m / Revenue TTM 906.3m)
Gross Margin = 88.01% ((Revenue TTM 906.3m - Cost of Revenue TTM 108.6m) / Revenue TTM)
Gross Margin QoQ = 86.81% (prev 87.92%)
Tobins Q-Ratio = 2.98 (Enterprise Value 4.69b / Total Assets 1.57b)
Interest Expense / Debt = 1849 % (Interest Expense 7.25m / Debt 392.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = -66.9m (EBIT -84.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.66 (Total Current Assets 1.51b / Total Current Liabilities 565.8m)
Debt / Equity = 0.00 (Debt 392.0k / totalStockholderEquity, last quarter 922.7m)
Debt / EBITDA = 3.04 (negative EBITDA) (Net Debt -224.2m / EBITDA -73.7m)
Debt / FCF = -0.93 (Net Debt -224.2m / FCF TTM 242.3m)
Total Stockholder Equity = 843.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -3.37% (Net Income -47.6m / Total Assets 1.57b)
RoE = -5.64% (Net Income TTM -47.6m / Total Stockholder Equity 843.4m)
RoCE = -10.03% (EBIT -84.7m / Capital Employed (Equity 843.4m + L.T.Debt 392.0k))
RoIC = -7.93% (negative operating profit) (NOPAT -66.9m / Invested Capital 843.4m)
WACC = 11.23% (E(5.89b)/V(5.89b) * Re(11.23%) + (debt cost/tax rate unavailable))
Discount Rate = 11.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.44%
[DCF Debug] Terminal Value 57.23% ; FCFF base≈242.3m ; Y1≈159.1m ; Y5≈72.6m
Fair Price DCF = 7.64 (EV 920.2m - Net Debt -224.2m = Equity 1.14b / Shares 149.8m; r=11.23% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 65.56 | EPS CAGR: 107.3% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.62 | Revenue CAGR: 35.69% | SUE: 1.98 | # QB: 2
EPS next Quarter (2026-04-30): EPS=0.20 | Chg30d=-0.002 | Revisions Net=-3 | Analysts=23
EPS next Year (2027-01-31): EPS=1.03 | Chg30d=-0.007 | Revisions Net=-1 | Growth EPS=+14.7% | Growth Revenue=+19.1%